Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04101188 · ClinicalTrials.gov registry record · NA
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
A NA study of Cardiovascular Risk Factor, sponsored by University of Delaware.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04101188: Recruiting NA study of Cardiovascular Risk Factor, sponsored by University of Delaware.
NCT04101188 is a NA study of Cardiovascular Risk Factor that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 90 participants, below the 3,065-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04101188, a NA study of Cardiovascular Risk Factor, is actively recruiting participants, sponsored by University of Delaware.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.
Primary Outcome
The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD
Conditions Studied
Interventions
- OTHER Moderate Potassium/Low Sodium Diet
- OTHER Moderate Potassium/High Sodium Diet
- OTHER High Potassium/High Sodium Diet
Study Locations (1)
Delaware
- University of Delaware - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT04101188 shows while recruiting
NCT04101188 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 3,065-participant average among 31 other Cardiovascular Risk Factor trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cardiovascular Risk Factor appearing as the primary indexed condition, and to 3 interventions - of which Moderate Potassium/Low Sodium Diet is the first listed.
NCT04101188 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT04101188 about?
NCT04101188 is a clinical study titled "Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans". Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet i...
What is the current status of trial NCT04101188?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2020-01-16. Estimated completion is 2026-07-31.
What conditions does trial NCT04101188 study?
This clinical trial studies the following conditions: Cardiovascular Risk Factor.
What interventions are being tested in trial NCT04101188?
The interventions under investigation include: Moderate Potassium/Low Sodium Diet (OTHER), Moderate Potassium/High Sodium Diet (OTHER), High Potassium/High Sodium Diet (OTHER).
Who is sponsoring clinical trial NCT04101188?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04101188 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Risk Factor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04101188's enrollment target sits among peer trials
90 13th of 31 higher than 19 of 31 other Cardiovascular Risk Factor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Risk Factor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
RECRUITING · NA
-
The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function
RECRUITING · NA
-
Sleep Duration and Cardiovascular Health
RECRUITING · NA
-
The Potassium Supplementation Study
RECRUITING · NA
-
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
ACTIVE NOT RECRUITING · NA
-
Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI